← All stocks

ONCOLYTICS BIOTECH INC

ONCY Net buying

CIK 0001129928 #4318 in the set updated 19 Sep 2026

Bought (12 mo)

$362.62K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$362.62K

+$362.62K against sales at will

By person

10 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Seizinger Bernd R.

Director

$187.22K (3)

—

+$187.22K

566,991

0.4447%

$544.31K

+54.5%

Kelly Jared

Chief Executive Officer

$34.37K (3)

—

+$34.37K

114,050

0.0894%

$109.49K

+54.3%

Andrews Patricia S

Director

$30.29K (1)

—

+$30.29K

78,128

0.0613%

$75.00K

+82.8%

Aromando Andrew

Chief Business Officer

$25.42K (1)

—

+$25.42K

55,100

0.0432%

$52.90K

+116.1%

Pisano Wayne

Director

$25.34K (1)

—

+$25.34K

492,414

0.3862%

$472.72K

+6.5%

Brown Deborah Margaret

Director

$21.24K (1)

—

+$21.24K

109,851

0.0862%

$105.46K

+29.5%

Parsons James T.

Director

$10.30K (1)

—

+$10.30K

41,849

0.0328%

$40.18K

+31.4%

Look Kirk

Chief Financial Officer

$10.10K (1)

—

+$10.10K

287,515

0.2255%

$276.01K

+4.4%

Heineman Thomas Charles

Chief Medical Officer

$10.03K (1)

—

+$10.03K

282,818

0.2218%

$271.51K

+4.5%

Hagerman Allison

Chief Technology Officer

$8.30K (1)

—

+$8.30K

115,059

0.0902%

$110.46K

+9.5%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 26

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 20 Jan 2026